Home |
Free Dividend Report |
Stock Splits Calendar |
VKTX Historical Stock Prices |
Preferred Stock Newsletter |
VKTX Options Chain |
Stock Message Boards |
Viking Therapeutics (VKTX) has the following price history information. Looking back at VKTX historical stock prices for the last five trading days, on April 18, 2024, VKTX opened at $66.13, traded as high as $66.25 and as low as $64.50, and closed at $64.67. Trading volume was a total of 2.41M shares. On April 19, 2024, VKTX opened at $64.54, traded as high as $65.80 and as low as $61.64, and closed at $63.42. Trading volume was a total of 3.06M shares. On April 22, 2024, VKTX opened at $64.13, traded as high as $64.94 and as low as $62.30, and closed at $63.85. Trading volume was a total of 1.56M shares. On April 23, 2024, VKTX opened at $64.45, traded as high as $67.58 and as low as $63.51, and closed at $64.93. Trading volume was a total of 2.03M shares. On April 24, 2024, VKTX opened at $65.75, traded as high as $67.78 and as low as $64.43, and closed at $65.07. Trading volume was a total of 2.57M shares.
VKTX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Viking Therapeutics shares, starting with a $10,000 purchase of VKTX, and working forward through the historical stock price information to today.
Growth of $10,000.00 Without Dividends Reinvested |
||
Start date: | 04/29/2015 | |
End date: | 04/24/2024 | |
Start price/share: | $8.96 | |
End price/share: | $65.07 | |
Dividends collected/share: | $0.00 | |
Total return: | 626.23% | |
Average Annual Total Return: | 24.66% | |
Starting investment: | $10,000.00 | |
Ending investment: | $72,613.87 | |
Years: | 8.99 |
VKTX Historical Price Range | |||||
Date | Open | High | Low | Close | Volume |
04/18/2024 | $66.13 | $66.25 | $64.50 | $64.67 | 2.41M |
04/19/2024 | $64.54 | $65.80 | $61.64 | $63.42 | 3.06M |
04/22/2024 | $64.13 | $64.94 | $62.30 | $63.85 | 1.56M |
04/23/2024 | $64.45 | $67.58 | $63.51 | $64.93 | 2.03M |
04/24/2024 | $65.75 | $67.78 | $64.43 | $65.07 | 2.57M |
About Viking Therapeutics |
Viking Therapeutics is a clinical-stage biopharmaceutical company focused on the development of therapies for metabolic and endocrine disorders. Co.'s primary clinical program's drug candidate, VK2809, is an orally available, tissue and receptor-subtype selective agonist of the thyroid hormone receptor beta (TRß). Co. is also developing VK0214, which is also an orally available, tissue and receptor-subtype selective agonist of TRß for X-linked adrenoleukodystrophy, a rare X-linked, inherited neurological disorder characterized by a breakdown in the protective barriers surrounding brain and nerve cells. |
VKTX Historical Closing Prices | |
Date | Close |
04/18/2024 | $64.67 |
04/19/2024 | $63.42 |
04/22/2024 | $63.85 |
04/23/2024 | $64.93 |
04/24/2024 | $65.07 |
Healthcare Historical Prices |
VKTX is categorized under the Healthcare sector; below are some other companies in the same sector:
VLRX Historical Stock Prices Also explore: VKTX shares outstanding history
Free VKTX Email Alerts:
|
VKTX Historical Stock Prices | www.HistoricalStockPrice.com | Copyright © 2013 - 2024, All Rights Reserved
Nothing in www.HistoricalStockPrice.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.Want to receive our latest research absolutely free?
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.